Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Heim

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Transplantation and Cellular Therapy|December 11, 2023
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCTKhalil Ben Hassine, Claire Seydoux, Sonia Khier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationAndreas Holbro, Thomas Lehmann, Sabine Girsberger, et al.
Swiss Medical Weekly|February 26, 2014
Forty years of haematopoietic stem cell transplantation: a review of the Basel experienceAlix O'Meara, Andreas Holbro, Sara Meyer, et al.
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Healthcare (Basel, Switzerland)|October 23, 2021
AI for Doctors-A Course to Educate Medical Professionals in Artificial Intelligence for Medical ImagingDennis M Hedderich, Matthias Keicher, Benedikt Wiestler, et al.
Cytotherapy|December 3, 2020
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myelomaAstrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, et al.
Blood|February 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trialAdalgisa Condoluci, Ilaria Romano, Daniel Dietrich, et al.
Leukemia Research|June 11, 2013
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignanciesCarlos Graux, Anne Sonet, Johan Maertens, et al.
Bone Marrow Transplantation|April 7, 2019
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Bone Marrow Transplantation|May 6, 2020
Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Transplantation and Cellular Therapy|December 11, 2023
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCTKhalil Ben Hassine, Claire Seydoux, Sonia Khier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationAndreas Holbro, Thomas Lehmann, Sabine Girsberger, et al.
Swiss Medical Weekly|February 26, 2014
Forty years of haematopoietic stem cell transplantation: a review of the Basel experienceAlix O'Meara, Andreas Holbro, Sara Meyer, et al.
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Healthcare (Basel, Switzerland)|October 23, 2021
AI for Doctors-A Course to Educate Medical Professionals in Artificial Intelligence for Medical ImagingDennis M Hedderich, Matthias Keicher, Benedikt Wiestler, et al.
Cytotherapy|December 3, 2020
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myelomaAstrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, et al.
Blood|February 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trialAdalgisa Condoluci, Ilaria Romano, Daniel Dietrich, et al.
Leukemia Research|June 11, 2013
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignanciesCarlos Graux, Anne Sonet, Johan Maertens, et al.
Bone Marrow Transplantation|April 7, 2019
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Bone Marrow Transplantation|May 6, 2020
Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Pageof 12